Description

Oltar (glimepiride) tablets 3 mg. №30

Ingredients

Active ingredient: Glimepiride 3 mg.
Other ingredients: Lactose monohydrate, microcrystalline cellulose, magnesium stearate, povidone, and colloidal silicon dioxide.

Dosage

Dosage: The usual starting dose is 1 to 2 mg once daily. Dosage adjustments should be made based on blood glucose monitoring.

Indications

Indications: Oltar tablets are indicated for the treatment of type 2 diabetes mellitus when diet, exercise, and weight reduction alone are not sufficient.

Contraindications

Contraindications: Do not use Oltar tablets in patients with a history of hypersensitivity to glimepiride or other sulfonylureas.

Directions

Directions: Take Oltar tablets orally with breakfast or the first main meal of the day. Follow the dosage instructions provided by your healthcare provider.

Scientific Evidence

Oltar (glimepiride) tablets 3 mg have been extensively studied for their efficacy in managing blood glucose levels in patients with type 2 diabetes mellitus. Clinical trials have shown that glimepiride, the active ingredient in Oltar, effectively stimulates insulin release from pancreatic beta cells, leading to improved glycemic control.

Moreover, a study published in the American Journal of Medicine demonstrated that glimepiride, when used as monotherapy or in combination with other antidiabetic agents, significantly reduced HbA1c levels and improved overall metabolic parameters in diabetic patients.

Additional Information

It is important to monitor blood glucose levels regularly while taking Oltar tablets to adjust the dosage as needed. Additionally, patients should be educated on the signs and symptoms of hypoglycemia and hyperglycemia to take appropriate action in case of glucose fluctuations.

Consult your healthcare provider before starting Oltar tablets, especially if you have liver or kidney impairment, as dose adjustments may be necessary to prevent potential adverse effects.